Andreas Geier Selected Research

Organic Anion Transporters

3/2007	Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.
12/2005	Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat.
11/2005	Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver.
9/2004	Interleukin-6 regulates hepatic transporters during acute-phase response.
8/2003	Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis.
1/2003	Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat.
8/2002	Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride.
6/2002	Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Geier Research Topics

Disease

24	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2005
18	Fibrosis (Cirrhosis) 04/2020 - 12/2003
17	Cholestasis 01/2016 - 06/2002
13	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2002
11	Chronic Hepatitis C 01/2020 - 02/2004
11	Liver Diseases (Liver Disease) 01/2019 - 12/2002
10	Fatty Liver 11/2020 - 12/2005
9	Infections 11/2018 - 01/2004
7	Neoplasms (Cancer) 06/2022 - 11/2006
7	Obesity 01/2022 - 12/2010
7	Inflammation (Inflammations) 01/2021 - 06/2002
7	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 12/2003
7	Alcoholic Fatty Liver 04/2020 - 01/2015
4	Hepatitis C 01/2020 - 01/2012
4	Sclerosing Cholangitis 01/2018 - 06/2002
4	Crohn Disease (Crohn's Disease) 01/2016 - 11/2006
3	Body Weight (Weight, Body) 01/2022 - 01/2016
3	Sepsis (Septicemia) 01/2022 - 02/2005
3	Liver Failure 03/2021 - 01/2015
3	Disease Progression 01/2019 - 08/2004
3	Anemia 10/2018 - 04/2013
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016 - 11/2006
3	Ulcerative Colitis 01/2016 - 11/2006
2	Weight Loss (Weight Reduction) 01/2022 - 01/2019
2	Lung Diseases (Lung Disease) 01/2022 - 01/2020
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2021 - 11/2014
2	Virus Diseases (Viral Diseases) 01/2020 - 08/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2015
2	Hemolytic Anemia 10/2018 - 12/2012
2	Cholangitis 10/2018 - 06/2002
2	Renal Insufficiency (Renal Failure) 10/2018 - 06/2011
2	Rheumatoid Arthritis 09/2017 - 01/2016
2	Insulin Resistance 01/2016 - 01/2016
2	Hypoxia (Hypoxemia) 10/2014 - 12/2013
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2012 - 04/2011
2	Breast Neoplasms (Breast Cancer) 08/2011 - 04/2004
2	Endotoxemia 03/2005 - 08/2003
1	Ascites 10/2022

Drug/Important Bio-Agent (IBA)

14	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 12/2002
11	CytokinesIBA 01/2021 - 08/2002
8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2003
8	Pharmaceutical PreparationsIBA 03/2021 - 12/2003
8	Proteins (Proteins, Gene)FDA Link 03/2020 - 06/2002
8	Organic Anion TransportersIBA 03/2007 - 06/2002
7	Vitamin D FDA LinkGeneric 01/2019 - 08/2011
6	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 02/2004
6	InterferonsIBA 01/2016 - 02/2004
6	Messenger RNA (mRNA)IBA 10/2014 - 06/2002
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2015
5	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019 - 01/2012
4	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 07/2012
4	Alanine Transaminase (SGPT)IBA 10/2019 - 11/2007
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2011 - 11/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 08/2003
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 03/2021 - 10/2006
3	LipidsIBA 01/2021 - 04/2015
3	EnzymesIBA 01/2019 - 01/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 09/2004
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 12/2010
3	IronIBA 12/2013 - 08/2004
3	Taurocholic Acid (Sodium Taurocholate)IBA 04/2013 - 11/2005
3	DNA (Deoxyribonucleic Acid)IBA 11/2005 - 01/2004
2	Volatile Fatty AcidsIBA 01/2022 - 12/2018
2	SugarsIBA 02/2021 - 01/2019
2	InterleukinsIBA 01/2021 - 01/2016
2	ElementsIBA 04/2020 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2020 - 03/2003
2	Peptides (Polypeptides)IBA 01/2020 - 10/2007
2	obeticholic acidIBA 12/2019 - 01/2016
2	AcidsIBA 10/2019 - 11/2008
2	nasIBA 01/2019 - 04/2013
2	AdiponectinIBA 01/2019 - 04/2013
2	CationsIBA 01/2019 - 02/2017
2	Interleukin-10 (Interleukin 10)IBA 10/2016 - 10/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 04/2013
2	Insulin (Novolin)FDA Link 01/2016 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 11/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2014 - 09/2012
2	AlbuminsIBA 06/2014 - 01/2012
2	Inosine TriphosphataseIBA 04/2013 - 12/2012
2	AutoantibodiesIBA 03/2013 - 02/2004
2	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 12/2012 - 09/2012
2	methyl 4-azidophenylacetimidate (APAI)IBA 09/2012 - 04/2012
2	Complement System Proteins (Complement)IBA 02/2012 - 08/2005
2	CarcinogensIBA 08/2011 - 04/2004
2	Multidrug Resistance-Associated Protein 2IBA 08/2011 - 04/2004
2	XenobioticsIBA 08/2011 - 12/2005
2	SodiumIBA 10/2007 - 12/2002
2	AnionsIBA 10/2007 - 04/2004
2	Matrix Metalloproteinases (MMPs)IBA 11/2006 - 06/2006
2	Trans-Activators (Trans-Acting Factor)IBA 12/2005 - 01/2003
2	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 11/2005 - 03/2005

Therapy/Procedure

27	Therapeutics 04/2022 - 03/2003
6	Liver Transplantation 01/2012 - 10/2006
5	Bariatric Surgery 01/2022 - 04/2013
2	Hepatectomy 03/2021 - 08/2002
2	Transplantation 01/2016 - 06/2011
2	Radiofrequency Ablation 02/2014 - 07/2012
1	Contraindications 10/2022
1	Transjugular Intrahepatic Portasystemic Shunt 10/2022